TECTONIC THERAPEUTIC INC (TECX)
Health Care · Clinical-stage GPCR-targeted biologic therapeutics · NASDAQ
A clinical-stage biotech developing novel GPCR-targeting biologics for rare pulmonary and bleeding disorders using its proprietary GEODe platform.
What TECTONIC THERAPEUTIC INC does
Tectonic Therapeutic is a clinical-stage biotechnology company focused on discovering and developing therapeutic proteins and antibodies that modulate the activity of GPCRs (G-protein coupled receptors). The company has developed a proprietary technology platform called GEODe to enable the discovery of GPCR-targeted biologic medicines targeting diseases with significant unmet medical need. Its lead product candidates are TX45, an Fc-relaxin fusion molecule for pulmonary hypertension, and TX2100, a VHH-Fc fusion antagonist antibody for hereditary hemorrhagic telangiectasia.
Themes: ["GPCR-targeted therapeutics","Pulmonary hypertension / heart failure","Hereditary hemorrhagic telangiectasia (HHT)","Interstitial lung disease (ILD)","Rare genetic bleeding disorders"]
Fundamentals
- Price$35.27 as of 2026-07-09 close
- Market cap$660M as of 2026-07-10
- 1-year return+72.1% as of 2026-07-09 close
- ROE-32.3% as of 2026-07-10
- Debt / equity0.00 as of 2026-07-10
- Beta1.30 as of 2026-07-10
Key risks (from latest filing)
["Clinical development risk: Lead programs TX45 and TX2100 are in Phase 2 and Phase 1a trials respectively, with no guarantee of success or regulatory approval.","Capital requirements: As a pre-revenue clinical-stage company, Tectonic requires significant ongoing funding to support drug development, clinical trials, and operations.","GPCR modulation complexity: The discovery and development of biologics that can modulate GPCRs has historically been challenging, and the company's platform may not overcome these inherent technical barriers."]
Competitors & peers
- Acceleron Pharma (rare disease biologics)
- Alnylam Pharmaceuticals (RNAi therapeutics for rare diseases)
- Regeneron Pharmaceuticals (biologic therapeutics and platform technology)
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.